methane has been researched along with marimastat in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Begay, JG; Campen, MJ; Denson, JL; Erdely, A; Fraser, K; Herbert, G; Hunter, R; Lucas, SN; Mostovenko, E; Ottens, AK; Salazar, R; Wang, T; Young, TL; Zychowski, K | 1 |
1 other study(ies) available for methane and marimastat
Article | Year |
---|---|
Pulmonary delivery of the broad-spectrum matrix metalloproteinase inhibitor marimastat diminishes multiwalled carbon nanotube-induced circulating bioactivity without reducing pulmonary inflammation.
Topics: Animals; Bronchoalveolar Lavage Fluid; Endothelial Cells; Hydroxamic Acids; Lung; Matrix Metalloproteinase Inhibitors; Mice; Mice, Inbred C57BL; Nanotubes, Carbon; Pneumonia | 2021 |